FDA Clearance Tracker · P990025-S007
NAVISTAR DIAGNOSTIC/ABLATION DEFLECTABLE TIP CATHETER
Last checked: Nov 20, 2026Latest source record: Sep 10, 2002 (this decision)Source: openFDAMethods & limitations
Decided
Sep 10, 2002
Approved
Time to decision
18 days
Received Aug 23, 2002. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track
Device class
Class II
The decision
- FDA number
- P990025-S007
- Device name
- NAVISTAR DIAGNOSTIC/ABLATION DEFLECTABLE TIP CATHETER
- Applicant
- Biosense Webster, Inc.
- Applicant location
- Irvine, CA
- Received
- Aug 23, 2002
- Decided
- Sep 10, 2002
- Decision
- Approved
- Supplement type
- Normal 180 Day Track
- Reason for supplement
- Express GMP Supplement
- Original approval
- P990025
Device type
- Device class
- Class II
- Regulation
- 21 CFR 870.1220
- Specialty
- Cardiology
FDA's approval statement
As written in FDA's record.
APPROVAL FOR AN ALTERNATE MANUFACTURING FACILITY LOCATED AT BIOSENSE WEBSTER, INC., CHIHUAHUA, MEXICO.
Source documents
Other decisions for Biosense Webster, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
- Dual Energy THERMOCOOL SMARTTOUCH SF SystemPMA supplement
P030031-S141 · Decided Jul 1, 2026 · 279 days after receipt · Panel Track
Device type: catheter, percutaneous, cardiac ablation, for treatment of atrial flutter (OAD) · Cardiology
7 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.